Nutex Health (NASDAQ:NUTX) Stock Rated Buy in New Coverage at LADENBURG THALM/SH SH

Research analysts at LADENBURG THALM/SH SH assumed coverage on shares of Nutex Health (NASDAQ:NUTX) in a report released on Monday, Briefing.com reports. The firm set a “buy” rating and a $336.00 price target on the stock. LADENBURG THALM/SH SH‘s price objective would indicate a potential upside of 60.31% from the company’s previous close.

Several other equities research analysts have also commented on NUTX. Zacks Research lowered shares of Nutex Health from a “strong-buy” rating to a “hold” rating in a report on Tuesday, October 6th. B. Riley Financial reiterated a “buy” rating on shares of Nutex Health in a research note on Friday, September 4th. Weiss Ratings upgraded Nutex Health from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Tuesday, October 6th. Lake Street Capital reissued a “buy” rating and issued a $310.00 price objective (up from $235.00) on shares of Nutex Health in a report on Tuesday, August 11th. Finally, Wall Street Zen upgraded Nutex Health from a “hold” rating to a “buy” rating in a research note on Saturday, October 3rd. Four investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to MarketBeat.com, Nutex Health has a consensus rating of “Moderate Buy” and a consensus target price of $323.67.

Nutex Health Stock Performance

Shares of NASDAQ NUTX opened at $209.59 on Monday. The company has a 50 day simple moving average of $201.41 and a two-hundred day simple moving average of $163.35. The stock has a market cap of $1.44 billion, a price-to-earnings ratio of 8.23 and a beta of 0.55. The company has a current ratio of 5.00, a quick ratio of 4.96 and a debt-to-equity ratio of 0.59. Nutex Health has a 12 month low of $83.99 and a 12 month high of $226.16.

Nutex Health (NASDAQ:NUTX) last released its quarterly earnings data on Thursday, August 6th. The company reported $9.38 earnings per share for the quarter, topping analysts’ consensus estimates of $4.95 by $4.43. Nutex Health had a net margin of 21.25% and a return on equity of 39.74%. The firm had revenue of $210.75 million for the quarter, compared to analyst estimates of $215.03 million. As a group, analysts predict that Nutex Health will post 27.58 earnings per share for the current year.

Insider Transactions at Nutex Health

In related news, Director Scott Saunders sold 203 shares of the firm’s stock in a transaction on Friday, September 18th. The shares were sold at an average price of $214.25, for a total transaction of $43,492.75. Following the sale, the director owned 400 shares in the company, valued at approximately $85,700. This trade represents a 33.67% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 44.68% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. BlackRock Inc. purchased a new stake in shares of Nutex Health during the 2nd quarter worth about $69,612,000. Winmill & CO. Inc. purchased a new position in shares of Nutex Health in the 2nd quarter valued at about $11,168,000. Empowered Funds LLC acquired a new position in Nutex Health in the 2nd quarter worth about $7,720,000. SG Americas Securities LLC raised its holdings in Nutex Health by 3,232.6% in the 1st quarter. SG Americas Securities LLC now owns 30,360 shares of the company’s stock worth $2,885,000 after purchasing an additional 29,449 shares during the period. Finally, Bank of New York Mellon Corp acquired a new position in Nutex Health in the 2nd quarter worth about $3,956,000. Hedge funds and other institutional investors own 5.32% of the company’s stock.

Nutex Health Company Profile

Nutex Health, Inc (NASDAQ:NUTX) is a physician-led healthcare services company that operates an integrated network of hospitals, medical facilities and physician practices in the United States. The company focuses on providing convenient, community-based care through its micro-hospitals and other healthcare locations.

Its hospital operations generally include emergency services, inpatient care, diagnostic testing and outpatient treatment. Nutex also operates physician networks and supports primary care and specialty providers.